Providing High-Quality and Affordable Intensive Care to Patients With Cancer: The Forgotten Brick in the Steep Wall of Costs Throughout the Cancer Care Continuum
+ Author Affiliations
- Corresponding author: Márcio Soares, MD, PhD, D'Or Institute for Research and Education, Rua Diniz Cordeiro, 30 -3 ° andar; Rio de Janeiro, Brazil, CEP 22281 -100; e-mail: marciosoaresms@gmail.com.
To the Editor:
The article by Shih et al1
summarized the activities of the workshop entitled “Delivering
Affordable Cancer Care in the 21st Century” led by the National
Cancer Policy Forum of the Institute of Medicine.
We congratulate the authors for such work that, as remarked by
themselves,
describes the challenges posed by the increasing
costs of cancer care as being exemplary of those facing the health care
system
as whole, driven significantly by an aging
population. Many concerns regarding the implications of the overuse
and/or inappropriate
use of screening and therapeutic strategies (in
particular, the new therapies and technologies) for the costs of cancer
care
were raised by the authors.
In addition, there is urgent need for
improvements in supportive care for these patients. In this sense, the
growing demand
for intensive care represents another critical and
forgotten facet of a complex problem. Intensive care–related costs in
the
United States (estimated at $82 billion in 2005)
account for 13% of hospital expenditures and approximately 1% of the
gross
domestic product.2
Although many targets to improve the provision of supportive care for
patients with cancer were addressed, the discussion
was restricted to palliative care. Nonetheless,
intensive care units (ICUs) are essential for the supportive care of
patients
with cancer; up to one in five patients admitted to
ICUs have cancer.3 It is well known that survival of critically ill patients with cancer has improved significantly in recent years, even in
the case of respiratory failure or severe infection.3 In contrast, many patients with cancer are still inappropriately admitted to the ICU at the end of life.4 However, because triage procedures are inaccurate even in specialized centers,5 the broadening of ICU admission policies has been recommended by experts worldwide.3
For all these reasons, the provision of
intensive care to an increasing number of patients with cancer deserves
to be included
in any future agenda of care planning for these
patients. Along this lines, future investigations should address the
roles
of fast-track postoperative care, planned recovery
tracks, dehospitalization programs, rehabilitation, and hospice-based
care
for patients with cancer who survive ICU stays.
Meanwhile, close collaboration between oncologists and intensivists
coupled
with the need to document patient preferences for
aggressive therapies and end-of-life issues at the time of ICU admission
are essential to avoid either depriving patients
who may benefit from life-sustaining treatments or, conversely,
inappropriately
prolonging the end of life. Integrating palliative
and intensive care is paramount to achieving high-quality and affordable
supportive care that will meet the needs of
patients, family members, care providers, and society.
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
The author(s) indicated no potential conflicts of interest.
No comments:
Post a Comment